Clinical Scenario · Reproductive Doctor Clinic Record
In overseas assisted reproductive clinical work, similar cases are not uncommon. Patients often equate "IVF failure" with "no pregnancy after transfer," but in reality, from ovarian stimulation, egg retrieval, fertilization, embryo culture to transfer, every step can be a watershed for failure. The following systematically breaks down the core causes and diagnostic logic of overseas IVF failure from a reproductive medicine perspective.
1. Four Core Causes of Overseas IVF Failure
According to clinical statistics and reproductive medicine consensus, overseas IVF failure can be summarized into the following four levels. A single factor or a combination of multiple factors can lead to cycle cancellation, no embryo available, or recurrent implantation failure.
| Cause Category | Specific Mechanism | Clinical Proportion (Reference) |
|---|---|---|
| Embryo Factors | Chromosomal aneuploidy, high sperm DNA fragmentation rate, abnormal fertilization, embryo developmental arrest | Approximately 50%–65% (significantly increases with age) |
| Maternal Factors | Insufficient endometrial receptivity, chronic endometritis, intrauterine adhesions/polyps, immune disorders, endocrine abnormalities | Approximately 20%–30% |
| Laboratory Factors | Unstable culture system, embryo biopsy damage, freeze-thaw loss, transfer operation details | Approximately 5%–10% |
| Protocol and Timing Factors | Mismatch between ovarian stimulation protocol and ovarian response, insufficient luteal support, displaced implantation window | Approximately 5%–10% |
2. Embryo Chromosomal Abnormalities—The Most Common and Difficult to Overcome Cause
Embryo chromosomal numerical abnormalities (aneuploidy) are the most significant single factor leading to overseas IVF failure. A normal embryo should have 46 chromosomes (23 pairs). Aneuploidy means having one more or one less chromosome, making it almost impossible for such embryos to implant normally or resulting in very early biochemical miscarriage.
Why does the incidence of aneuploidy increase with age?
The risk of chromosome segregation errors during female oocyte meiosis increases exponentially with age. The aneuploidy rate in embryos is about 30%–40% for women under 35, rising to 60%–70% at ages 40–42, and reaching 80%–90% for those over 42. Male factors are also important—when the sperm DNA fragmentation rate (DFI) exceeds 30%, even if fertilization is successful, embryos are prone to stop dividing in early culture.
Can PGT screening solve all problems?
Preimplantation genetic testing (PGT) can screen for chromosomally normal embryos, improving the success rate per transfer. However, PGT has limitations: ① Not all embryos can develop to the blastocyst stage for biopsy; ② Biopsy may cause potential damage to the embryo; ③ There are challenges in diagnosing mosaic embryos. The use of PGT strategies varies greatly among overseas centers; some routinely recommend it for all cycles, while others only for advanced age or recurrent failure groups. Whether PGT is suitable needs to be evaluated based on embryo quantity, laboratory capabilities, and patient willingness.
3. Clinical Diagnostic Logic for "Low Oocyte Count" and "Poor Embryo Quality"
Facing "overseas IVF failure with no embryo available," the reproductive doctor's diagnostic pathway usually proceeds in the following order:
- Step 1: Verify baseline data—AMH, antral follicle count (AFC), FSH, LH, E2, to determine if ovarian reserve matches age. AMH < 1.0 ng/mL and AFC < 5 indicate poor ovarian response as a primary cause.
- Step 2: Analyze previous ovarian stimulation protocols—Was an individualized protocol used? Were the Gn starting dose, trigger timing, number of oocytes retrieved, and mature oocyte rate reasonable?
- Step 3: Evaluate fertilization and embryo culture records—Fertilization method (IVF/ICSI), normal fertilization rate, day 3 good-quality embryo rate, blastocyst formation rate. If the blastocyst formation rate is below 20%, focus on egg/sperm quality and culture system.
- Step 4: Investigate male factors—Semen analysis + DNA fragmentation rate + chromosome karyotype. Y chromosome microdeletions, Robertsonian translocations, etc., can directly cause embryo developmental arrest.
In clinical practice, about 40% of "no embryo available" cases are ultimately attributed to underestimated male factors. The frequency of simultaneous examination of both partners in overseas IVF is lower than domestically, which is an easily overlooked blind spot.
4. Differences in Overseas IVF Failure Causes Across Countries
Reproductive centers in different overseas countries or regions have differences in laboratory standards, operational protocols, and medical culture. These differences directly affect the failure rate and type of failure.
| Country/Region | Common Failure Pattern | Related Factors |
|---|---|---|
| United States | Low blastocyst culture rate, no embryo transferable after PGT | Widespread use of PGT-A, high embryo quality requirements, some centers have a high discard rate for mosaic embryos |
| Thailand | Insufficient oocyte retrieval, low fertilization rate | Some centers lack experience with poor ovarian responders, stimulation protocols tend to be conservative |
| Japan | Recurrent implantation failure, high biochemical pregnancy rate | High use of mild stimulation protocols, fewer oocytes retrieved but meticulous endometrial preparation, some centers have strict embryo grading |
| Russia/Ukraine | High cycle cancellation rate, significant embryo freeze-thaw loss | Longer equipment update cycles, differences in vitrification technology in some centers |
| Malaysia | Unsatisfactory ovarian stimulation response, high cycle conversion cost | Drug import restrictions limit some stimulation protocol options |
When choosing an overseas center, one should not only look at the single "success rate" number but also understand the center's specific data and experience with advanced age, low reserve, and recurrent failure patients.
5. Four Most Easily Overlooked Details
In the investigation of overseas IVF failure causes, the following indicators are often missed by patients and even some centers, yet they are key pieces of the puzzle determining success or failure.
- ① Sperm DNA Fragmentation Rate (DFI)—Even if routine semen analysis is normal, DFI > 25%–30% can significantly affect embryo developmental potential. The emphasis on DFI varies among overseas centers; some do not include it as a routine test.
- ② Vitamin D Level—Serum 25-hydroxyvitamin D < 30 ng/mL is associated with decreased endometrial receptivity and lower embryo implantation rates. It is particularly common in people with low sun exposure or long-term indoor work.
- ③ Thyroid Function and Autoantibodies—TSH > 2.5 mIU/L or positive thyroid peroxidase antibodies (TPO-Ab) are associated with early pregnancy loss and recurrent implantation failure. Some overseas centers have a higher TSH threshold (>4.0), potentially missing the intervention window.
- ④ Chronic Endometritis (CE)—Asymptomatic chronic endometritis has a detection rate of 30%–60% in women with recurrent implantation failure. Standard hysteroscopy + endometrial biopsy + CD138 immunohistochemistry is the gold standard for diagnosis. The routine use of hysteroscopy varies greatly among overseas centers.
6. Key Diagnostic Indicators and Clinical Interpretation
Identifying the cause of overseas IVF failure requires objective indicators rather than subjective speculation. The following are reference ranges for commonly used clinical indicators (slight variations exist between different laboratories):
The above indicators are not independent; they need to be interpreted comprehensively in clinical practice. For example, a combination of AMH 0.6 + FSH 13 + AFC 4 suggests that low ovarian reserve is the main cause of failure. In this case, priority should be given to strategies for improving egg quality or evaluating egg donation, rather than blindly changing the stimulation protocol.
7. Frequently Asked Questions
8. Three Common Misconceptions in Investigating Overseas IVF Failure
- Misconception 1: "This failure is due to poor egg quality; taking some supplements will fix it."
The core factors affecting egg quality are age and genetic background. The clinical evidence for supplements like DHEA, Coenzyme Q10, and melatonin is limited and cannot replace cause investigation. Blindly taking them may delay the discovery of the real cause. - Misconception 2: "A normal PGT result guarantees implantation."
PGT detects chromosomal number and large structural abnormalities but cannot rule out single-gene disorders, mitochondrial abnormalities, or epigenetic issues. Even with a normal PGT embryo, the implantation rate is about 50%–65%, and endometrial factors remain an important variable. - Misconception 3: "Overseas IVF failure means my body is too weak; I need a full year of recovery before trying again."
For women of advanced age or with diminished ovarian reserve, time is the most expensive cost. Unless there are clear medical contraindications (e.g., uncontrolled autoimmune disease, untreated intrauterine adhesions), it is recommended to proceed to the next cycle as soon as possible after investigation, rather than indefinitely "recovering."
9. Practitioner Observation: The Real-World Failure Chain
In overseas coordination work, a typical failure chain is often not a single cause but an accumulation of "minor deviations" in multiple steps:
Example: A 39-year-old patient, AMH 1.2, underwent a standard antagonist protocol at a center in Country A, retrieved 7 oocytes, 5 mature, 4 fertilized via ICSI, only 1 blastocyst (grade BC) on day 5, and PGT-A result was abnormal. In a second cycle at a center in Country B, a PPOS protocol was used, retrieved 6 oocytes, 4 mature, 3 fertilized, 2 blastocysts (BB, BC) on day 6, 1 normal PGT-A, but no implantation after transfer. Review revealed: ① The laboratory incubator in the first cycle had an unreported alarm; ② Endometrial microbiome testing was not done before the second transfer, and later a low proportion of Lactobacillus was found. The third transfer was successful after adjusting the protocol.
This case illustrates that investigating the causes of overseas IVF failure needs to run through all stages, from laboratory quality control to the maternal internal environment. Any detail can become an "invisible weak link."
▎ Reproductive Doctor's Advice
After an overseas IVF failure, the most needed thing is a systematic cause investigation rather than an emotional "try another place." It is recommended to proceed in the following order:
- Complete a comprehensive examination for both partners (Female: AMH, AFC, TSH, Vitamin D, hysteroscopy + endometrial biopsy; Male: semen analysis + DFI + chromosome karyotype);
- Obtain complete laboratory records from previous cycles (number of oocytes retrieved, maturity rate, fertilization rate, embryo grading, culture days, freeze-thaw data);
- Work with the reproductive doctor to formulate an improvement plan for the next cycle (change stimulation protocol, adjust ICSI timing, add assisted hatching, consider PGT, etc.);
- If the original center cannot provide the above investigations or communication is insufficient, you can take your medical records for a second opinion, but avoid blindly changing countries.
Every patient's cause of failure is unique. Finding it is more important than blindly starting the next cycle.
Reproductive Medicine Knowledge Base · Overseas Assisted Reproduction Special Topic | Content Review: Reproductive Medicine Editorial Group | For learning reference only, not a basis for clinical decision-making
Comments (0)